» Articles » PMID: 12534423

Male Drugs-related Deaths in the Fortnight After Release from Prison: Scotland, 1996-99

Overview
Journal Addiction
Specialty Psychiatry
Date 2003 Jan 22
PMID 12534423
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To assess if 15-35-year-old males released after 14 + days' imprisonment in Scotland, 1996-99, had a higher drugs-related death rate in 2 weeks after release than during subsequent 10 weeks; higher than expected death rate from other causes; and if drugs-related deaths in the first fortnight were three times as many as prison suicides.

Design: Confidential linkage of ex-prisoner database against deaths.

Setting: Scotland's male prisons and young offenders' institutions during July to December 1996-99; 19 486 index releases after 14+ days' incarceration.

Measurements: Relative risk of drugs-related death in the first 2 weeks after release (34 deaths) versus subsequent 10 weeks (23). Other causes of death (21) relative to expectation. Drugs-related deaths in first 2 weeks after release relative to suicides in prison (12).

Findings: Drugs-related mortality in 1996-99 was seven times higher (95% CI: 3.3-16.3) in the 2 weeks after release than at other times at liberty and 2.8 times higher than prison suicides (95% CI: 1.5-3.5) by males aged 15-35 years who had been incarcerated for 14+ days. We estimated one drugs-related death in the 2 weeks after release per 200 adult male injectors released from 14 + days' incarceration. Non-drugs-related deaths in the 12 weeks after release were 4.9 times (95% CI: 2.8-7.0) the 4.3 deaths expected.

Conclusion: Investment in, and evaluation of, prison-based interventions is needed to reduce substantially recently released drugs-related deaths.

Citing Articles

"Catching Chain" With Medicaid: The Impact of Medicaid Access on Opioid Overdose Mortality in Adults Released From State Detention.

Blumberger L, Calo W, Mallinson D, Liu G, Leslie D Psychiatr Res Clin Pract. 2024; 6(3):94-103.

PMID: 39568500 PMC: 11574460. DOI: 10.1176/appi.prcp.20230080.


Reducing overdose deaths among persons with opioid use disorder in connecticut.

Scheidell J, Townsend T, Zhou Q, Manandhar-Sasaki P, Rodriguez-Santana R, Jenkins M Harm Reduct J. 2024; 21(1):103.

PMID: 38807226 PMC: 11131266. DOI: 10.1186/s12954-024-01026-6.


Sex differences in suicide, suicidal ideation, and self-harm after release from incarceration: a systematic review and meta-analysis.

Janca E, Keen C, Willoughby M, Borschmann R, Sutherland G, Kwon S Soc Psychiatry Psychiatr Epidemiol. 2022; 58(3):355-371.

PMID: 36462041 PMC: 9971066. DOI: 10.1007/s00127-022-02390-z.


Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.

Bazazi A, Culbert G, Wegman M, Heimer R, Kamarulzaman A, Altice F BMC Infect Dis. 2022; 22(1):837.

PMID: 36368939 PMC: 9652918. DOI: 10.1186/s12879-022-07804-6.


Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran.

Armoon B, Griffiths M, Bayani A, Mohammadi R, Ahounbar E Addict Sci Clin Pract. 2022; 17(1):42.

PMID: 35927753 PMC: 9351099. DOI: 10.1186/s13722-022-00325-2.